beta-D-GclpNAc-(1->2)-[beta-D-GlcpNAc-(1->3)]-D-Galp

Term ID

CHEBI:147074

Synonyms

2-acetamido-2-deoxy-beta-D-gluco-hexopyranosyl-(1->2)-[2-acetamido-2-deoxy-beta-D-gluco-hexopyranosyl-(1->3)]-D-galacto-hexopyranose
2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->2)-[2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->3)]-D-galactopyranose
GlcNAc(b1-2)[GlcNAc(b1-3)]Gal
N-[(2S,3R,4R,5S,6R)-2-[(3R,4S,5S,6R)-3-[(2S,3R,4R,5S,6R)-3-Acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide

Definition

An amino trisaccharide that is D-galactopyranose in which the hydroxy groups at positions 2 and 3 have each been converted into the corresponding 2-acetamido-2-deoxy-β-D-glucopyranosyl derivative.

References

glygen:G06931TP
glytoucan:G06931TP
kegg.glycan:G12429

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from beta-D-GclpNAc-(1->2)-[beta-D-GlcpNAc-(1->3)]-D-Galp

Phenotype where environments contain beta-D-GclpNAc-(1->2)-[beta-D-GlcpNAc-(1->3)]-D-Galp

Phenotype modified by environments containing beta-D-GclpNAc-(1->2)-[beta-D-GlcpNAc-(1->3)]-D-Galp

Phenotype affecting beta-D-GclpNAc-(1->2)-[beta-D-GlcpNAc-(1->3)]-D-Galp

Human Disease Model